ALL THE LATEST NEWS ABOUT THE BUSINESS OF PC GAMES

News

Remedy now has six games in the works

Remedy now has six games in the works

Finnish games firm Remedy has started work on another project.

In its financial report for the three months ending March 31st, 2021, company CEO Tero Virtala (pictured) said that staff on Control had "moved onto work on other Remedy projects, including a new, exciting early-phase project."

During Remedy's call with investors – as reported by IGN – the exec was asked whether this was a brand new game.

"Yes, we have a new project," Virtala said. "But it is in very, very early stages. Nothing more to expand on that.”

Remedy is also currently working on single-player modes for Smilegate's CrossFire X and CrossFire HD shooters, its two projects that are being published by Epic Games, as well as free-to-play co-op title Vanguard.

As of December 2020, Control has shifted more than two million copies since its release in August 2019.

For the quarter between January and March, Remedy brought in €8.1 million ($9.8 million) in revenue, a 3.4 per cent increase year-on-year.

"In the bigger context of our fast-growing global market, we have proven our ability to create category-defining brands and games," Virtala said.

"During the past years, we have built an organization that can create multiple high-quality games in parallel. In line with our updated strategy for 2021–2025, to capture more of the future value these games generate, we are now expanding also to self-financing and self-publishing."


PCGamesInsider Contributing Editor

Alex Calvin is a freelance journalist who writes about the business of games. He started out at UK trade paper MCV in 2013 and left as deputy editor over three years later. In June 2017, he joined Steel Media as the editor for new site PCGamesInsider.biz. In October 2019 he left this full-time position at the company but still contributes to the site on a daily basis. He has also written for GamesIndustry.biz, VGC, Games London, The Observer/Guardian and Esquire UK.